1. Apoptosis MAPK/ERK Pathway
  2. RIP kinase Mixed Lineage Kinase Necroptosis
  3. SZM-1209

SZM-1209 是一种口服有效且特异性的 RIPK1 抑制剂,Kd 为 85 nM。 SZM-1209 表现出高抗坏死性凋亡(necroptosis) 活性 (EC50=22.4 ± 8.1 nM)。 SZM-1209 具有抗 SIRS (全身炎症反应综合征)和抗 ALI (急性肺损伤)作用。

MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务

SZM-1209 Chemical Structure

SZM-1209 Chemical Structure

CAS No. : 2919801-86-6

1.  客户无需承担相应的运输费用。

2.  同一机构(单位)同一产品试用装仅限申领一次,同一机构(单位)一年内

     可免费申领三个不同产品的试用装。

3.  试用装只面向终端客户

规格 是否有货
50 mg   询价  
100 mg   询价  
250 mg   询价  

* Please select Quantity before adding items.

Customer Review

  • 生物活性

  • 纯度 & 产品资料

  • 参考文献

生物活性

SZM-1209 is an orally active, potent and specific RIPK1 inhibitor, with a Kd of 85 nM. SZM-1209 exhibits high anti-necroptotic activity (EC50=22.4 ± 8.1 nM). SZM-1209 shows anti-SIRS (systemic inflammatory response syndrome), and anti-ALI (acute lung injury) effects[1].

IC50 & Target

RIPK1

85 nM (Kd)

RIPK3

>10000 nM (Kd)

体外研究
(In Vitro)

SZM-1209 以剂量依赖的方式阻断坏死性凋亡[1]
SZM-1209 (0-1 μM, 6 h) 特异性抑制 RIPK1-RIPK3-MLKL 坏死性凋亡信号的磷酸化[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: HT-29 cells
Concentration: 0.1, 0.5, and 1 μM
Incubation Time: 6 h
Result: SZM-1209 at 1 μM completely inhibited phosphorylation of both RIPK1 and RIPK3 in 2-6 h, and subsequently inhibited the phosphorylation of downstream MLKL.
体内研究
(In Vivo)

SZM-1209 (25-100 mg/kg, 灌胃) 在 mTNF-α 诱导的全身炎症反应综合征 (SIRS) 模型中具有显著的抗炎作用,可以逆转小鼠死亡[1]
SZM-1209 (25-100 mg/kg, 腹腔注射) 通过减少肺水肿和病理损伤显着减轻 ALI (急性肺损伤)[1]

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: C57BL/6J mice (female, 6-8 weeks old, mTNF-α (intravenous injection)-induced SIRS model)[1]
Dosage: 25, 50, and 100 mg/kg
Administration: Intragastric administration
Result: Dose-dependently improved survival rates of the SIRS mice to 30, 90, and 100%. Could effectively protect against mTNFα-induced SIRS in vivo. Serum levels of IL-6 and IL-1β were significantly decreased.
Animal Model: C57BL/6J mice (female, 6-8 weeks old, NNK (HY-126477) (65 mg/kg) short-term intratracheal exposure-induced ALI model)[1]
Dosage: 25, 50, and 100 mg/kg
Administration: IP
Result: Exhibited lower levels of IL-6 and TNF-α in BALF than those of model mice. Inhibited the expression of inflammatory genes of IL-6 and TNF-α in lung tissues of mice at a mRNA level. Significant reduced phosphorylation of RIPK1, and also completely blocked at a high dose of 100 mg/kg in lung tissue of ALI model mice.
分子量

696.71

Formula

C31H29F5N4O5S2

CAS 号
运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Please store the product under the recommended conditions in the Certificate of Analysis.

纯度 & 产品资料
参考文献
  • 摩尔计算器

  • 稀释计算器

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

质量   浓度   体积   分子量 *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

浓度 (start) × 体积 (start) = 浓度 (final) × 体积 (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

您最近查看的产品:

Your information is safe with us. * Required Fields.

   产品名称:

 

* 需求量:

* 客户姓名:

 

* Email:

* 电话:

 

* 公司或机构名称:

   留言给我们:

Bulk Inquiry

Inquiry Information

产品名称:
SZM-1209
目录号:
HY-149052
需求量: